Author:
Cygon Franziska,Meinert Fabian
Publisher
Springer Berlin Heidelberg
Reference47 articles.
1. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Deutschen Krebsgesellschaft (DKG), Deutsche Krebshilfe (DKH) (2017) S3 Leitlinie Supportive Therapie 04/2017, S 194–202
2. Balagula Y, Rosen ST, Lacouture ME (2011) The emergence of supportive oncodermatology: the study of dermatologic adverse events to cancer therapies. J Am Acad Dermatol 65:624–635
3. Betticher DC, Delmore G, Breitenstein U et al (2013) Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment. Support CareCancer 21:2565–2573
4. Botchkarev VA, Komarova EA, Siebenhaar F et al (2000) p53 is essential for chemotherapy-induced hair loss. Cancer Res 60:5002–5006
5. Breed WPM, van den Hurk CJG, Peerbooms M (2011) Presentation, impact and prevention of chemotherapy-induced hair loss: scalp cooling potentials and limitations. Expert Rev Dermatol 6:109–125